Serkan Durdu

Suggest Changes
Learn More
OBJECTIVE Cell therapy for patients with ischaemic cardiomyopathy (IC) is still an open issue. We aimed to assess the long-term safety and therapeutic potency of autologous bone marrow mononuclear(More)